MRNA logo

Moderna, Inc.

MRNA
Healthcare|Biotechnology|US
$254.19
+12.73 (+5.27%)
Tangible Book / Share
$17.05
Cash / Share
$12.90

Clinical Trials (1)

TrialConditionsPhaseStatusEnrollmentDesignDrug
NCT05668741
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Cystic Fibrosis
P1P2
Completed26Open-labelVX-522 mRNA therapy, IVA